--(BUSINESS WIRE)--The initial focus of CardiAQ Valve Technologies' platform is a Transcatheter Mitral Valve Implantation (TMVI) system designed to be an effective alternative to open-chest surgery for treating mitral regurgitation. The Company's mission is to develop and commercialize cost effective, catheter based valve replacement systems that restore long term function to patients with failing mitral valves.
|
Company: |
CardiAQ Valve Technologies | |
|
Headquarters Address: |
2 Jenner, Ste. #100 | |
| Irvine, CA 926187 | ||
|
Main Telephone: |
949-387-2615 |
|
|
Website: |
||
|
Type of Organization: |
Private | |
| PR | ||
|
Industry: |
Medical Devices | |
|
Key Executives: |
CEO: Rob Michiels |
|
|
President: Brent Ratz |
||
|
Public Relations |
||
|
Contact: |
Ronald Trahan | |
|
Phone: |
5083594005 | |
|
Email: |
